About Myriad RBM, Inc.
Myriad RBM, Inc. is a leading company that specializes in the quantitative measurement of over 300 protein biomarkers to support pharmacodynamic, prognostic, and predictive clinical studies. The company has a CLIA certified testing lab that ensures accurate and reliable results for its clients.
With over 20 years of experience in the industry, Myriad RBM has established itself as a trusted partner for pharmaceutical and biotech companies looking to advance their drug development programs. The company's innovative technology platform allows for the simultaneous measurement of multiple biomarkers from small sample volumes, providing valuable insights into disease pathways and treatment efficacy.
One of the key advantages of working with Myriad RBM is its extensive menu of validated assays covering a wide range of therapeutic areas such as oncology, inflammation, cardiovascular disease, metabolic disorders, and neurology. This enables clients to select the most relevant biomarkers for their specific research needs and obtain comprehensive data on drug response and patient stratification.
In addition to its core laboratory services, Myriad RBM offers customized assay development services tailored to meet unique client requirements. This includes feasibility studies, assay optimization, validation testing, and transfer to manufacturing.
The company's commitment to quality is reflected in its rigorous quality control processes that ensure reproducibility across different batches and instruments. Myriad RBM also participates in external proficiency testing programs to maintain high standards of accuracy and precision.
Myriad RBM's team comprises experienced scientists with expertise in various disciplines such as biochemistry, immunology, molecular biology, statistics among others. They work closely with clients throughout the project lifecycle from study design through data analysis providing scientific guidance at every step.
The company's state-of-the-art facility located in Austin Texas houses cutting-edge equipment including Luminex xMAP technology which enables multiplexed analysis of up to 500 analytes simultaneously using microspheres coated with capture antibodies specific for each target protein.
In conclusion,
Myriad RBM is an industry leader when it comes to quantitative measurement of protein biomarkers supporting pharmacodynamic clinical studies through their CLIA certified lab services.
Their extensive menu covers various therapeutic areas enabling clients' selection based on their research needs.
They offer customized assay development services tailored specifically towards meeting unique client requirements.
Their team comprises experienced scientists who provide scientific guidance throughout every step from study design through data analysis.
Finally,
their state-of-the-art facility located in Austin Texas houses cutting-edge equipment including Luminex xMAP technology which enables multiplexed analysis up-to 500 analytes simultaneously using microspheres coated with capture antibodies specific for each target protein making them one-stop-shop solution provider for all your clinical study needs!